Title : ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.

Pub. Date : 2011 Jun 1

PMID : 21482676






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a mouse model of mammary carcinoma driven by the polyomavirus middle T (PyVmT) oncogene, the ErbB2 tyrosine kinase inhibitor lapatinib reduced the activation of ErbB3 and Akt as well as tumor cell growth. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus
2 In this phosphatidylinositol-3 kinase (PI3K)-dependent tumor model, ErbB2 is part of a complex containing PyVmT, p85 (PI3K), and ErbB3, that is disrupted by treatment with lapatinib. Lapatinib erb-b2 receptor tyrosine kinase 2 Mus musculus